QSA's Week in BioPharma (#4, 2025)
Health Canada proposes tighter precursor chemical regulations; MP discusses national Pharmacare progress; rare disease drug access funding.
Read next
Lobbying Landscapes in BioPharma (June, 2025)
Genome Canada; Innovative Medicines Canada; Abbott Laboratories Co.; Hoffmann-La Roche Limited; Novartis Pharmaceuticals Canada Inc.; Gilead Sciences Canada
QSA's Week in BioPharma (#21, 2025)
QSA's Week in BioPharma (#20, 2025)
Major pharma partnership for IND filing; bio innovation grants in Alberta; new domestic vaccine initiative; European patent grant notice; Senators speak on research security, microplastics; MPs address vaccination, fentanyl sentencing.